«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:

期数:

2023年02期

页码:

190-194

栏目:

论著

出版日期:

2023-04-20

文章信息/Info

Title:

Primary mucinous adenocarcinoma of the lung: three cases report and literature review

作者:

王妮妮¹ 陈荣荣¹ 张青¹ 张诚实¹ 崔栋慧¹ 伍健² 雷撼¹ 赵云峰¹

200125 上海,上海市浦东新区浦南医院呼吸内科¹、病理科²

Author(s):

Wang Nini¹;  Chen Rongrong¹;  Zhang Qing¹;  Zhang Chengshi¹;  Cui Donghui¹;  Wu Jian²;  Lei Han¹;  Zhao Yunfeng¹.

¹Department of Respiratory; ²Department of pathology Punan Hospital, Pudong New Area, Shanghai 200125, China

关键词:

原发性肺黏液腺癌;  浸润性黏液腺癌;  文献复习

Keywords:

Primary mucinous lung adenocarcinoma;  Invasive mucinous adenocarcinoma;  Literature review

分类号:

R734.2

DOI:

10.3877/cma.j.issn.1674-6902.2023.02.008

摘要:

目的 分析原发性肺黏液腺癌(primary pulmonary mucinous adenocarcinoma, PPMA)的临床表现、影像学特征、病理特点、治疗等,提高临床对该病的认识。方法 选择2022年6月至2022年10月收治的3例原发性肺黏液腺癌的临床诊治经过,3例为女性,年龄73～85岁,为高龄。结合文献复习,提高对原发性肺黏液腺癌临床表现、影像学特征、病理特点等认识,提高诊断及治疗水平。结果 原发性肺黏液腺癌以浸润性黏液腺癌为主,临床表现无特异性,易被误诊,诊断主要依靠病理,治疗以早期手术为主。结论 原发性肺黏液腺癌是肺腺癌的一种特殊亚型,临床诊断缺乏特异性,诊断主要依赖活组织病理。

Abstract:

Objective To investigate the clinical manifestations, imaging features and pathological characteristics of primary pulmonary mucinous adenocarcinoma(PPMA)and improve the understanding of the disease. Methods Through the clinical diagnosis and treatment of 3 cases of primary mucinous lung adenocarcinoma from June 2022 to October 2022 was analyzed. All of them were female, aged 73 to 85 old. Combined with literature analysis and literature review, to strengthen clinicians'understanding of the clinical manifestations, imaging characteristics and pathological characteristics of this disease, improve the level of diagnosis and treatment. Results The primary mucinous adenocarcinoma of the lung was mainly invasive mucinous adenocarcinoma. The clinical manifestations were not specific, and it was easy to be misdiagnosed. The diagnosis mainly depended on pathology, and the treatment was mainly early operation. Conclusion PPMA is a special subtype of lung adenocarcinoma with low incidence and poor prognosis. The lack of specificity in clinical diagnosis mainly depends on biopsy.

参考文献/References:

1 孙瑞琼, 王 爽. 原发性肺黏液腺癌多层螺旋CT影像表现[J/CD]. 中华肺部疾病杂志(电子版), 2022, 15(2): 260-262.
2 Travis WD, Brambilla E, Burke AP, et al. Introduction to the 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart[J]. J Thorac Oncol, 2015, 10(9): 1240-1242.
3 Türüt H, Demirag F, Gulhan E, et al. Primary pulmonary mucinous adenocarcinoma in a 15-year-old boy[J]. Eur J Cardiothorac Surg, 2006, 29(5): 851-853.
4 Babiy Y, Sychova T, Dykan I. Radiological aspects of the new “International multidisciplinary classification of lung adenocarcinoma”: Methodological bases and own experience[J]. Radiation Diagnostics Radiation Therapy, 2019(4): 55-71.
5 Choi Y, Kim KH, Jeong BH, et al. Clinicoradiopathological features and prognosis according to genomic alterations in patients with resected lung adenocarcinoma[J]. J Thorac Dis, 2020, 12(10): 5357-5368.
6 Blackstone N, El-Aini T. Medical image of the month: Mucinous adenocarcinoma of the lung mimicking pneumonia[J]. Southwest J Pulmonary and Cri Care, 2021, 22(1):8-10.
7 Shim HS, Kenudson M, Zheng Z, et al. Unique genetic and survival characteristics of invasive mucinous adenocarcinoma of the lung[J]. J Thorac Oncol, 2015, 10(8): 1156-1162.
8 Geles A, Gruber-Moesenbacher U, Quehenberger F, et al. Pulmonary mucinous adenocarcinomas: architectural patterns in correlation with genetic changes, prognosis and survival[J]. Virchows Arch, 2015, 467(6): 675-686.
9 Austin JH, Garg K, Aberle D, et al. Radiologic implications of the 2011 classification of adenocarcinoma of the lung[J]. Radiology, 2013, 266(1): 62-71.
10 Shenoy V, Buckley M, Hosseini H, et al. S1710 signet ring cell mucinous adenocarcinoma of the colon manifesting as intermittent hiccups[J]. Official J American College of Gastroenterology ACG, 2020, 115(1): 882-883.
11 Sun F, Wang P, Zheng Y, et al. Diagnosis, clinicopathological characteristics and prognosis of pulmonary mucinous adenocarcinoma[J]. Oncol Lett, 2018, 15(1): 489-494.
12 周 蕾. 79例肺原发性粘液腺癌的临床分析[D]. 大连医科大学, 2017: 1-5.
13 魏朋华. 原发性肺粘液腺癌的临床病理及分子特征的回顾性分析[D]. 山东大学, 2020: 3-8.
14 Moon SW, Choi SY, Moon MH. Effect of invasive mucinous adenocarcinoma on lung cancer-specific survival after surgical resection: a population-based study[J]. J Thorac Dis, 2018, 10(6): 3595-3608.
15 Boland JM, Maleszewski JJ, Wampfler JA, et al. Pulmonary invasive mucinous adenocarcinoma and mixed invasive mucinous/nonmucinous adenocarcinoma-a clinicopathological and molecular genetic study with survival analysis[J]. Hum Pathol, 2018, 71: 8-19.
16 Cha YJ, Kim HR, Lee HJ, et al. Clinical course of stage Ⅳ invasive mucinous adenocarcinoma of the lung[J]. Lung Cancer, 2016, 102: 82-88.
17 Kim DH, Bae SY, Na KJ, et al. Radiological and clinical features of screening-detected pulmonary invasive mucinous adenocarcinoma[J]. Interact Cardiovasc Thorac Surg, 2022, 34(2): 229-235.
18 Blackstone N, El-Aini T. Medical image of the month: Mucinous adenocarcinoma of the lung mimicking pneumonia[J]. Southwest J Pulmonary and Critical Care, 2021, 22(1): 8-10.
19 Perre SV, Duron L, Milon A, et al. Radiomic analysis of HTR-DCE MR sequences improves diagnostic performance compared to BI-RADS analysis of breast MR lesions[J]. Eur Radiol, 2021, 31(7): 4848-4859.
20 Nakaoku T, Tsuta K, Ichikawa H, et al. Druggable oncogene fusions in invasive mucinous lung adenocarcinoma[J]. Clin Cancer Res, 2014, 20(12): 3087-3093.
21 Shin DH, Lee D, Hong DW, et al. Oncogenic function and clinical implications of SLC3A2-NRG1 fusion in invasive mucinous adenocarcinoma of the lung[J]. Oncotarget, 2016, 7(43): 69450-69465.
22 Laskin J, Liu SV, Tolba K, et al. NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents[J]. Ann Oncol, 2020, 31(12): 1693-1703.
23 Guo M, Tomoshige K, Meister M, et al. Gene signature driving invasive mucinous adenocarcinoma of the lung[J]. EMBO Mol Med, 2017, 9(4): 462-481.
24 Duruisseaux M, Antoine M, Rabbe N, et al. Lepidic predominant adenocarcinoma and invasive mucinous adenocarcinoma of the lung exhibit specific mucin expression in relation with oncogenic drivers[J]. Lung Cancer, 2017, 109: 92-100.
25 Milewski D, Balli D, Ustiyan V, et al. FOXM1 activates AGR2 and causes progression of lung adenomas into invasive mucinous adenocarcinomas[J]. PLoS Genet, 2017, 13(12): e1007097.
26 Truini A, Santos Pereira P, Cavazza A, et al. Classification of different patterns of pulmonary adenocarcinomas[J]. Expert Rev Respir Med, 2015, 9(5): 571-586.
27 Lantuejoul S, Rouquette I, Brambilla E, et al. [New WHO classification of lung adenocarcinoma and preneoplasia][J]. Ann Pathol, 2016, 36(1): 5-14.
28 Lee HJ, Lee CH, Jeong YJ, et al. IASLC/ATS/ERS International Multidisciplinary Classification of Lung Adenocarcinoma: novel concepts and radiologic implications[J]. J Thorac Imaging, 2012, 27(6): 340-353.
29 Kuhn E, Morbini P, Cancellieri A, et al. Adenocarcinoma classification: patterns and prognosis[J]. Pathologica, 2018, 110(1): 5-11.
30 Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma[J]. J Thorac Oncol, 2011, 6(2): 244-285.

备注/Memo

备注/Memo:

基金项目: 上海市浦东新区卫生系统重点亚专科建设资助(PWZy2020-15)
上海市浦东新区卫生系统临床特色学科建设资助(PWYts2021-04)
上海市浦东新区卫生系统重点学科建设资助(PWZxk2022-24)
通信作者: 赵云峰, Email: yfzh71@126.com

常用功能

更新日期/Last Update: 2023-04-20